Predicted to enable ATP binding activity; identical protein binding activity; and protein kinase binding activity. Predicted to be involved in defense response to virus; necroptotic process; and protein homotrimerization. Predicted to be located in several cellular components, including cell junction; cytosol; and nucleus. Predicted to be active in cytoplasm. Orthologous to human MLKL (mixed lineage kinase domain like pseudokinase); INTERACTS WITH 1,3-dichloropropan-2-ol; 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLKL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MLKL mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of MLKL mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLKL mRNA and Melatonin inhibits the reaction [bisphenol A results in increased expression of MLKL protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MLKL mRNA
[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MLKL mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA more ...
[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of MLKL mRNA
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA more ...
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLKL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MLKL mRNA
dihydrotanshinone I inhibits the reaction [[Lipopolysaccharides co-treated with benzyloxycarbonyl-valyl-alanyl-aspartic acid] results in increased expression of MLKL protein modified form] and dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of MLKL protein]
galangin inhibits the reaction [Doxorubicin results in increased phosphorylation of MLKL protein] and GSK2795039 inhibits the reaction [Doxorubicin results in increased phosphorylation of MLKL protein]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLKL mRNA
3-methyladenine inhibits the reaction [Ethanol results in increased expression of and results in increased phosphorylation of MLKL protein] and Ethanol results in increased expression of and results in increased phosphorylation of MLKL protein
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA more ...
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA more ...
[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA more ...
necrostatin-1 inhibits the reaction [Hydrogen Peroxide results in increased expression of MLKL protein] and Phycocyanin inhibits the reaction [Hydrogen Peroxide results in increased expression of MLKL protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLKL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MLKL mRNA
[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MLKL mRNA
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL mRNA]] more ...
Melatonin inhibits the reaction [bisphenol A results in increased expression of MLKL protein] and Melatonin inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MLKL protein]
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL mRNA]] more ...
[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MLKL mRNA
necrostatin-1 inhibits the reaction [Oleic Acid results in increased phosphorylation of MLKL protein] and PGAM5 protein promotes the reaction [Oleic Acid results in increased phosphorylation of MLKL protein]
Minocycline inhibits the reaction [Paclitaxel results in increased expression of MLKL protein] and necrostatin-1 inhibits the reaction [Paclitaxel results in increased expression of MLKL protein]
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MLKL mRNA
[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MLKL mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MLKL mRNA
[Acetylcysteine results in decreased abundance of Reactive Oxygen Species] inhibits the reaction [Lipopolysaccharides promotes the reaction [Polystyrenes results in increased expression of MLKL mRNA]] more ...
Rimonabant inhibits the reaction [Quetiapine Fumarate affects the localization of MLKL protein] and Rimonabant inhibits the reaction [Quetiapine Fumarate results in increased expression of and results in increased phosphorylation of MLKL protein]
necrostatin-1 inhibits the reaction [Silicon Dioxide results in increased phosphorylation of MLKL protein] and Silicon Dioxide results in increased expression of and results in increased phosphorylation of MLKL protein
[ZFP91 protein co-treated with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone co-treated with SM 164 co-treated with TNF protein] results in increased phosphorylation of MLKL protein
[TNF protein co-treated with SM 164 co-treated with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone] results in increased phosphorylation of MLKL protein
[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MLKL mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLKL mRNA